Die neuesten CRVS Reports werden am 2024-05-07 aktualisiert: 2024-Q12023-Q42023-Q1
Corvus Pharmaceuticals logo
Corvus Pharmaceuticals CRVS
€ 1.88 3.57%

Corvus Pharmaceuticals Kennzahlen 2011-2024 | CRVS

Kennzahlen Jährlich Corvus Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-3.5 -0.7 -1.7 -17.1 -3.5 -2.3 -3.4 -5.9 - - - - -

P/S

- - - - - - - - - - - - -

EPS

-0.6 -0.9 -1.0 -0.2 -1.6 -1.7 -2.7 -2.4 -83.9 -0.9 - - -

EV (Enterprise Value)

88.4 M 29.7 M 22.9 M 99.5 M 169 M 76 M 155 M 216 M 125 M 171 K - - -

EBITDA per Share

-0.48 -0.69 -0.91 -1.46 -1.64 -1.76 -2.72 -2.36 - - - - -

EV/EBITDA

0.2 -2.2 -3.2 -1.4 -2.6 -5.7 - - - - -

PEG

0.16 0.03 0.11 -0.21 -0.49 -0.06 0.22 0.11 - - - - -

P/B

2.4 0.5 0.8 1.4 2.3 1.0 2.2 1.6 - - - - -

P/CF

-3.9 -1.1 -2.0 -2.9 -4.3 -2.6 -4.1 -7.1 - - - - -

ROE %

-69.87 -73.61 -44.50 -8.31 -65.63 -42.54 -65.61 -27.39 - - - - -

ROA %

-59.34 -60.53 -39.51 -7.01 -55.80 -39.70 -58.73 -25.95 - - - - -

ROCE %

-60.51 -58.03 -39.76 -60.65 -66.54 -44.26 -65.87 -27.55 - - - - -

Current Ratio

6.6 5.6 8.9 6.4 7.8 16.4 10.2 22.9 - - - - -

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Corvus Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.12 - -0.12 -0.14 -0.17 - -0.32 -0.18 -0.18 -0.2 -0.24 -0.28 -0.34 0.92 -0.33 -0.36 -0.44 -0.38 -0.37 -0.44 -0.4 -0.36 -0.36 -0.4 -0.63 -0.58 -0.62 -0.73 -0.79 -0.55 -0.51 -0.43 -5.39 -13.31 -7.97 -58.42 -6.44 - - - - - - - - - - - - - - - -

EBITDA per Share

-0.13 - -0.11 -0.12 -0.14 - -0.27 -0.15 -0.16 - -0.2 -0.26 -0.33 - -0.32 -0.35 -0.44 - -0.37 -0.45 -0.41 - -0.36 -0.41 -0.64 - -0.6 -0.72 -0.79 - -0.5 -0.43 -5.37 - -7.66 -6.63 -7.45 - - - - - - - - - - - - - - - -

ROE %

-57.32 -42.80 -65.73 -75.11 -72.37 -42.58 -52.73 -39.95 -41.74 -34.61 3.29 -0.13 -2.65 -8.31 -61.75 -63.64 -67.19 -65.63 -59.62 -53.66 -45.95 -42.54 -47.08 -52.55 -59.67 -65.61 -59.90 -52.66 -41.51 -27.39 0.37 18.26 89.82 100.75 81.34 71.20 6.15 - - - - - - - - - - - - - - - -

ROA %

-48.53 -36.28 -54.74 -61.65 -59.48 -35.69 -44.63 -35.12 -36.82 -30.29 1.69 -0.82 -2.49 -7.01 -52.19 -53.89 -57.00 -55.80 -51.48 -47.20 -41.52 -39.70 -43.40 -47.94 -53.91 -58.73 -54.06 -47.98 -38.35 -25.95 -24.18 -20.03 -34.41 -31.83 -25.69 -22.49 -1.94 - - - - - - - - - - - - - - - -

ROCE %

-55.21 -37.37 -56.65 -63.38 -60.74 -36.27 -44.87 -34.19 -37.18 -32.48 -46.13 -51.17 -54.38 -46.96 -63.15 -65.70 -69.89 -52.61 -62.72 -56.63 -48.62 -34.49 -49.74 -54.90 -61.67 -52.26 -60.15 -52.78 -41.54 -19.37 -9.34 8.58 22.72 24.65 24.65 14.62 7.12 - - - - - - - - - - - - - - - -

Current Ratio

6.0 6.6 6.8 6.8 6.2 5.6 5.1 7.6 8.8 8.9 8.4 8.4 7.4 6.4 6.4 6.4 6.4 6.7 6.7 6.7 6.7 15.0 15.0 15.0 15.0 9.5 9.5 9.5 9.5 19.1 19.1 19.1 19.1 26.1 26.1 26.1 26.1 - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung